Failure of Daratumumab Therapy for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes Syndrome

J Clin Neuromuscul Dis. 2021 Sep 1;23(1):56-58. doi: 10.1097/CND.0000000000000370.
No abstract available

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • POEMS Syndrome* / drug therapy
  • Polyneuropathies* / drug therapy

Substances

  • Antibodies, Monoclonal
  • daratumumab